Sex hormones skew outcomes in clinical trials -- here's how

17 Aug 2016


In an Essay published in Cell Metabolism, a group argues that hormones and other variables make a difference in how potential therapeutics behave, and both males and females must be accounted for in trials to move medical advances forward.

EurekAlert


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story